With the opening of airside pharma and healthcare hubs in Brussels and Johannesburg, Kuehne+Nagel has added two strategic elements to its global GxP-certified network of temperature-controlled facilities for the distribution of vaccines and other pharmaceutical and healthcare products.
Since many of the temperature-sensitive products have very low to no stability outside of their stated temperature ranges, direct tarmac access at Kuehne+Nagel airside facilities further minimises the risk of temperature excursions and ensures product integrity during the logistics journey. The new premises have dedicated areas for all ranges of temperature-sensitive products. In addition, these facilities have the ability to change or add dry ice as required for deep frozen shipments where temperatures need to be maintained below -60°C.
In Brussels, the new Air Logistics hub is located in the centre of Brucargo at the airport, incidenatlly the first airport in the world with an IATA CEIV pharma certification. The new Kuehne+Nagel facility consists of 15,546 square metres of warehousing space and is fully connected to the recently extended Geel Contract Logistics pharma warehousing facility, as well as the pan-European KN PharmaChain Road Logistics Network managed from Luxembourg.
In Johannesburg, the expanded KN PharmaChain airside facility at the international airport answers all temperature-sensitive cargo handling, consolidation and storage requirements and offers a number of value-added logistics services before further distribution in South Africa or into Africa. Additionally, the new facility provides a unique temperature-controlled airside solution through the use of state-of-the-art KN PharmaChain cool dollies. Built to accommodate both lower deck and main deck pallet sizes, the cool dollies protect the integrity of the cargo coming from the aircraft.